What is Omnicell Com's earnings per share (EPS)?

Omnicell Com (OMCL) reported diluted earnings per share of $0.04 for fiscal year 2025. This represents a -85.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Omnicell Com Financials

OMCL

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Omnicell Com (OMCL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 39/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Omnicell Com has an operating margin of 0.4%, meaning the company retains $0 of operating profit per $100 of revenue. This below-average margin results in a low score of 23/100, suggesting thin profitability after operating expenses. This is up from 0.0% the prior year.

Growth

Omnicell Com's revenue grew 6.5% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 44/100.

Leverage

Omnicell Com carries a low D/E ratio of 0.60, meaning only $0.60 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Omnicell Com's current ratio of 1.43 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 24/100, which could limit financial flexibility.

Cash Flow

Omnicell Com has a free cash flow margin of 7.3%, earning a moderate score of 43/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Omnicell Com generates a 0.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100. This is down from 1.0% the prior year.

Altman Z-Score Grey Zone

2.25

Omnicell Com scores 2.25, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($1.5B) relative to total liabilities ($742.9M). This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Strong

7/9

Omnicell Com passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

62.04x

For every $1 of reported earnings, Omnicell Com generates $62.04 in operating cash flow ($127.3M OCF vs $2.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY+6.5%

5Y CAGR+5.8%

10Y CAGR+9.4%

Omnicell Com generated $1.2B in revenue in fiscal year 2025. This represents an increase of 6.5% from the prior year.

EBITDA

$84.0M

YoY+1.7%

5Y CAGR-2.8%

10Y CAGR+1.2%

Omnicell Com's EBITDA was $84.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.7% from the prior year.

Net Income

$2.1M

YoY-83.6%

5Y CAGR-42.3%

10Y CAGR-23.7%

Omnicell Com reported $2.1M in net income in fiscal year 2025. This represents a decrease of 83.6% from the prior year.

EPS (Diluted)

$0.04

YoY-85.2%

5Y CAGR-44.2%

10Y CAGR-26.2%

Omnicell Com earned $0.04 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 85.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$86.9M

YoY-42.6%

5Y CAGR-11.8%

10Y CAGR+10.9%

Omnicell Com generated $86.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 42.6% from the prior year.

Cash & Debt

$196.5M

YoY-46.8%

5Y CAGR-16.6%

10Y CAGR+9.1%

Omnicell Com held $196.5M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

45M

YoY-2.9%

5Y CAGR+1.0%

10Y CAGR-1.8%

Omnicell Com had 45M shares outstanding in fiscal year 2025. This represents a decrease of 2.9% from the prior year.

Margins & Returns

Gross Margin

42.5%

YoY+0.1pp

5Y CAGR-3.8pp

10Y CAGR-8.7pp

Omnicell Com's gross margin was 42.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the prior year.

Operating Margin

0.4%

YoY+0.4pp

5Y CAGR-3.5pp

10Y CAGR-9.6pp

Omnicell Com's operating margin was 0.4% in fiscal year 2025, reflecting core business profitability. This is up 0.4 percentage points from the prior year.

Net Margin

0.2%

YoY-1.0pp

5Y CAGR-3.4pp

10Y CAGR-6.2pp

Omnicell Com's net profit margin was 0.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.0 percentage points from the prior year.

Return on Equity

0.2%

YoY-0.8pp

5Y CAGR-3.2pp

10Y CAGR-7.2pp

Omnicell Com's ROE was 0.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$88.7M

YoY-1.9%

5Y CAGR+4.8%

10Y CAGR+9.7%

Omnicell Com invested $88.7M in research and development in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

Share Buybacks

$77.6M

5Y CAGR+7.9%

10Y CAGR+4.5%

Omnicell Com spent $77.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$40.4M

YoY+10.8%

5Y CAGR+12.1%

10Y CAGR+18.3%

Omnicell Com invested $40.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 10.8% from the prior year.

OMCL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.2B+6.5%	$1.1B-3.0%	$1.1B-11.5%	$1.3B+14.5%	$1.1B+26.9%	$892.2M
Cost of Revenue	$681.4M+6.3%	$641.2M-1.4%	$650.3M-8.0%	$707.0M+22.4%	$577.4M+20.6%	$478.9M
Gross Profit	$503.4M+6.9%	$471.0M-5.2%	$496.8M-15.6%	$589.0M+6.2%	$554.7M+34.2%	$413.3M
R&D Expenses	$88.7M-1.9%	$90.4M-6.9%	$97.1M-7.5%	$105.0M+38.6%	$75.7M+7.9%	$70.2M
SG&A Expenses	$409.6M+7.7%	$380.3M-12.5%	$434.6M-10.6%	$486.3M+24.9%	$389.4M+26.6%	$307.6M
Operating Income	$5.2M+1431.2%	$337K+101.0%	-$34.9M-1401.0%	-$2.3M-102.6%	$89.5M+151.9%	$35.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$9.3M-29.0%	$13.1M+4866.5%	$263K+103.2%	-$8.1M+31.6%	-$11.8M-316.2%	-$2.8M
Net Income	$2.1M-83.6%	$12.5M+161.5%	-$20.4M-460.7%	$5.6M-92.7%	$77.8M+141.8%	$32.2M
EPS (Diluted)	$0.04-85.2%	$0.27+160.0%	$-0.45-475.0%	$0.12-92.6%	$1.62+118.9%	$0.74

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$314.0M+1.1%	$310.6M+6.9%	$290.6M+7.7%	$269.7M-12.1%	$306.9M+8.7%	$282.4M+2.0%	$276.8M+12.4%	$246.2M
Cost of Revenue	$183.7M+4.3%	$176.1M+8.1%	$162.9M+2.6%	$158.7M-3.9%	$165.1M+3.1%	$160.2M-1.4%	$162.4M+5.8%	$153.5M
Gross Profit	$130.3M-3.1%	$134.5M+5.3%	$127.7M+15.1%	$110.9M-21.7%	$141.8M+15.9%	$122.3M+6.9%	$114.4M+23.5%	$92.6M
R&D Expenses	$22.6M-6.1%	$24.0M+11.3%	$21.6M+5.1%	$20.5M-21.2%	$26.0M+22.7%	$21.2M+0.5%	$21.1M-4.3%	$22.1M
SG&A Expenses	$107.4M+5.0%	$102.2M+4.3%	$98.0M-4.0%	$102.0M-1.3%	$103.3M+9.4%	$94.5M+5.0%	$90.0M-2.6%	$92.4M
Operating Income	$415K-95.0%	$8.2M+1.5%	$8.1M+169.9%	-$11.6M-193.7%	$12.4M+88.8%	$6.6M+103.6%	$3.2M+114.8%	-$21.8M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$2.7M-35.7%	$4.2M-11.9%	$4.8M+292.0%	-$2.5M-132.3%	$7.8M+158.9%	$3.0M-32.8%	$4.5M+307.1%	-$2.2M
Net Income	-$2.0M-137.1%	$5.5M-3.1%	$5.6M+180.3%	-$7.0M-144.3%	$15.8M+83.6%	$8.6M+131.1%	$3.7M+123.8%	-$15.7M
EPS (Diluted)	N/A	$0.120.0%	$0.12+180.0%	$-0.15	N/A	$0.19+137.5%	$0.08+123.5%	$-0.34

OMCL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$2.0B-6.9%	$2.1B-4.8%	$2.2B+0.7%	$2.2B+3.2%	$2.1B+17.4%	$1.8B
Current Assets	$680.1M-16.6%	$815.5M-12.1%	$927.6M+5.2%	$881.8M+13.0%	$780.7M-5.9%	$829.4M
Cash & Equivalents	$196.5M-46.8%	$369.2M-21.1%	$468.0M+41.7%	$330.4M-5.4%	$349.1M-28.2%	$485.9M
Inventory	$100.9M+13.8%	$88.7M-19.5%	$110.1M-25.4%	$147.5M+23.0%	$119.9M+24.5%	$96.3M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$737.9M+0.4%	$734.7M-0.1%	$735.8M+0.2%	$734.3M-0.6%	$738.9M+48.0%	$499.3M
Total Liabilities	$742.9M-15.4%	$877.6M-15.4%	$1.0B-4.0%	$1.1B+8.5%	$995.8M+16.2%	$857.0M
Current Liabilities	$476.6M-20.0%	$595.7M+62.0%	$367.8M-14.2%	$428.4M-51.1%	$876.2M+217.0%	$276.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.2B-0.9%	$1.2B+4.6%	$1.2B+5.2%	$1.1B-1.4%	$1.1B+18.5%	$967.5M
Retained Earnings	$384.9M+0.5%	$382.9M+3.4%	$370.4M-5.2%	$390.7M+6.0%	$368.6M+26.8%	$290.7M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$2.0B+1.3%	$1.9B-9.2%	$2.1B-0.3%	$2.2B+1.4%	$2.1B-7.9%	$2.3B+0.5%	$2.3B+0.3%	$2.3B
Current Assets	$680.1M+3.1%	$659.6M-21.9%	$844.8M+0.6%	$839.7M+3.0%	$815.5M-19.4%	$1.0B+1.6%	$995.7M+0.6%	$989.9M
Cash & Equivalents	$196.5M+9.1%	$180.1M-54.9%	$399.0M+3.1%	$386.8M+4.8%	$369.2M-35.3%	$570.6M+2.5%	$556.8M+8.7%	$512.4M
Inventory	$100.9M-6.1%	$107.4M+1.6%	$105.8M+16.1%	$91.1M+2.8%	$88.7M-6.7%	$95.1M+1.9%	$93.3M-9.9%	$103.5M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$737.9M0.0%	$737.9M-0.1%	$738.5M+0.3%	$736.0M+0.2%	$734.7M-0.3%	$737.2M+0.2%	$735.4M0.0%	$735.4M
Total Liabilities	$742.9M+2.1%	$727.7M-17.5%	$881.9M-1.4%	$894.4M+1.9%	$877.6M-18.1%	$1.1B-1.5%	$1.1B-0.6%	$1.1B
Current Liabilities	$476.6M+4.4%	$456.6M-23.2%	$594.4M-2.2%	$607.5M+2.0%	$595.7M-38.0%	$961.5M+136.2%	$407.1M-2.2%	$416.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.2B+0.9%	$1.2B-3.4%	$1.3B+0.5%	$1.3B+1.1%	$1.2B+1.0%	$1.2B+2.4%	$1.2B+1.2%	$1.2B
Retained Earnings	$384.9M-0.5%	$387.0M+1.4%	$381.5M+1.5%	$375.9M-1.8%	$382.9M+4.3%	$367.0M+2.4%	$358.4M+1.1%	$354.7M

OMCL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$127.3M-32.2%	$187.7M+3.7%	$181.1M+132.8%	$77.8M-66.4%	$231.8M+24.7%	$185.9M
Capital Expenditures	$40.4M+10.8%	$36.5M-12.1%	$41.5M-12.8%	$47.5M+64.1%	$29.0M+26.8%	$22.8M
Free Cash Flow	$86.9M-42.6%	$151.3M+8.3%	$139.6M+361.6%	$30.2M-85.1%	$202.8M+24.4%	$163.0M
Investing Cash Flow	-$60.4M-14.3%	-$52.8M+4.0%	-$55.0M+6.2%	-$58.7M+85.8%	-$412.5M-47.4%	-$279.9M
Financing Cash Flow	-$218.3M+7.3%	-$235.6M-1105.9%	$23.4M+211.8%	-$21.0M-144.2%	$47.4M-89.6%	$456.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$77.6M	$0	$0-100.0%	$52.2M	$0-100.0%	$53.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$30.4M+7.4%	$28.3M-33.9%	$42.8M+64.9%	$25.9M-54.0%	$56.3M+147.5%	$22.8M-61.2%	$58.7M+17.5%	$50.0M
Capital Expenditures	$7.7M-21.0%	$9.8M-17.2%	$11.8M+5.5%	$11.2M+22.9%	$9.1M+2.5%	$8.9M-7.2%	$9.6M+6.6%	$9.0M
Free Cash Flow	$22.6M+22.3%	$18.5M-40.2%	$31.0M+110.0%	$14.8M-68.8%	$47.2M+240.1%	$13.9M-71.7%	$49.1M+19.9%	$41.0M
Investing Cash Flow	-$14.4M-1.0%	-$14.3M+10.3%	-$15.9M-1.2%	-$15.7M-16.0%	-$13.6M-1.7%	-$13.3M+1.6%	-$13.5M-9.8%	-$12.3M
Financing Cash Flow	$9.1M+104.1%	-$220.0M-1818.0%	-$11.5M-384.0%	$4.0M+101.7%	-$234.4M-6696.2%	$3.6M+121.4%	-$16.6M-239.4%	$11.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$61.9M	N/A	N/A	$0	$0	N/A	N/A

OMCL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	42.5%+0.1pp	42.4%-1.0pp	43.3%-2.1pp	45.5%-3.5pp	49.0%+2.7pp	46.3%
Operating Margin	0.4%+0.4pp	0.0%+3.1pp	-3.0%-2.9pp	-0.2%-8.1pp	7.9%+3.9pp	4.0%
Net Margin	0.2%-1.0pp	1.1%+2.9pp	-1.8%-2.2pp	0.4%-6.4pp	6.9%+3.3pp	3.6%
Return on Equity	0.2%-0.8pp	1.0%+2.7pp	-1.7%-2.2pp	0.5%-6.3pp	6.8%+3.5pp	3.3%
Return on Assets	0.1%-0.5pp	0.6%+1.5pp	-0.9%-1.2pp	0.3%-3.4pp	3.6%+1.9pp	1.8%
Current Ratio	1.43+0.1	1.37-1.2	2.52+0.5	2.06+1.2	0.89-2.1	3.00
Debt-to-Equity	0.60-0.1	0.71-0.2	0.87-0.1	0.96+0.1	0.87-0.0	0.89
FCF Margin	7.3%-6.3pp	13.6%+1.4pp	12.2%+9.8pp	2.3%-15.6pp	17.9%-0.4pp	18.3%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	41.5%-1.8pp	43.3%-0.6pp	43.9%+2.8pp	41.1%-5.0pp	46.2%+2.9pp	43.3%+2.0pp	41.3%+3.7pp	37.6%
Operating Margin	0.1%-2.5pp	2.6%-0.1pp	2.8%+7.1pp	-4.3%-8.3pp	4.0%+1.7pp	2.3%+1.2pp	1.2%+10.0pp	-8.9%
Net Margin	-0.7%-2.4pp	1.8%-0.2pp	1.9%+4.5pp	-2.6%-7.8pp	5.2%+2.1pp	3.1%+1.7pp	1.4%+7.7pp	-6.4%
Return on Equity	-0.2%-0.6pp	0.4%0.0pp	0.4%+1.0pp	-0.6%-1.8pp	1.3%+0.6pp	0.7%+0.4pp	0.3%+1.6pp	-1.3%
Return on Assets	-0.1%-0.4pp	0.3%+0.0pp	0.3%+0.6pp	-0.3%-1.1pp	0.8%+0.4pp	0.4%+0.2pp	0.2%+0.9pp	-0.7%
Current Ratio	1.43-0.0	1.44+0.0	1.42+0.0	1.38+0.0	1.37+0.3	1.05-1.4	2.45+0.1	2.38
Debt-to-Equity	0.600.0	0.60-0.1	0.70-0.0	0.710.0	0.71-0.2	0.87-0.0	0.91-0.0	0.92
FCF Margin	7.2%+1.2pp	6.0%-4.7pp	10.7%+5.2pp	5.5%-9.9pp	15.4%+10.5pp	4.9%-12.8pp	17.8%+1.1pp	16.7%

Similar Companies

Phreesia PHR

$509.6M

Certara, Inc. CERT

$875.3M

Goodrx Holdings, Inc. GDRX

$688.6M

10X Genomics, Inc. TXG

$2.8B

Schrodinger, Inc. SDGR

$852.7M

Frequently Asked Questions

What is Omnicell Com's annual revenue?

Omnicell Com (OMCL) reported $1.2B in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Omnicell Com's revenue growing?

Omnicell Com (OMCL) revenue grew by 6.5% year-over-year, from $1.1B to $1.2B in fiscal year 2025.

Is Omnicell Com profitable?

Yes, Omnicell Com (OMCL) reported a net income of $2.1M in fiscal year 2025, with a net profit margin of 0.2%.

What is Omnicell Com's EBITDA?

Omnicell Com (OMCL) had EBITDA of $84.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Omnicell Com's gross margin?

Omnicell Com (OMCL) had a gross margin of 42.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Omnicell Com's operating margin?

Omnicell Com (OMCL) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Omnicell Com's net profit margin?

Omnicell Com (OMCL) had a net profit margin of 0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Omnicell Com's return on equity (ROE)?

Omnicell Com (OMCL) has a return on equity of 0.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Omnicell Com's free cash flow?

Omnicell Com (OMCL) generated $86.9M in free cash flow during fiscal year 2025. This represents a -42.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Omnicell Com's operating cash flow?

Omnicell Com (OMCL) generated $127.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Omnicell Com's total assets?

Omnicell Com (OMCL) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Omnicell Com's capital expenditures?

Omnicell Com (OMCL) invested $40.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Omnicell Com spend on research and development?

Omnicell Com (OMCL) invested $88.7M in research and development during fiscal year 2025.

Does Omnicell Com buy back shares?

Yes, Omnicell Com (OMCL) spent $77.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Omnicell Com have outstanding?

Omnicell Com (OMCL) had 45M shares outstanding as of fiscal year 2025.

What is Omnicell Com's current ratio?

Omnicell Com (OMCL) had a current ratio of 1.43 as of fiscal year 2025, which is considered adequate.

What is Omnicell Com's debt-to-equity ratio?

Omnicell Com (OMCL) had a debt-to-equity ratio of 0.60 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Omnicell Com's return on assets (ROA)?

Omnicell Com (OMCL) had a return on assets of 0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Omnicell Com's Altman Z-Score?

Omnicell Com (OMCL) has an Altman Z-Score of 2.25, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Omnicell Com's Piotroski F-Score?

Omnicell Com (OMCL) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Omnicell Com's earnings high quality?

Omnicell Com (OMCL) has an earnings quality ratio of 62.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Omnicell Com?

Omnicell Com (OMCL) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.